The cell-mediated immune response to human papillomavirus-induced cervical cancer: Implications for immunotherapy

This publication has 143 references indexed in Scilit:

• Cytokine Profile of Cervical Cancer Cells
  Gynecologic Oncology, 2001
• Quantitative analysis of IL-10 and IFN-? mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer
  The Journal of Pathology, 2001
• HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans afterin vitro vaccination
  International Journal of Cancer, 2001
• Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma
  European Journal of Immunology, 1999
• Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice
  Cancer Gene Therapy, 1999
• CANCER BIOLOGY: The human papillomavirus E6/E7 genes induce discordant changes in the expression of cell growth regulatory proteins
  Carcinogenesis: Integrative Cancer Research, 1996
• Lack of interleukin‐2 (IL‐2) expression and selective expression of IL‐10 mRNA in human renal cell carcinoma
  International Journal of Cancer, 1995
• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
  European Journal of Immunology, 1993
• Tumour-infiltrating lymphocytes in cervical carcinoma
  European Journal Of Cancer, 1992
• MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding
  Nature, 1991